ProCE Banner Activity

Importance of Personalized and Multimodal Treatment: Key Insights From Recent Expert Presentations

Clinical Thought

An expert synthesizes key insights from recent presentations on the importance of a personalized and multimodal treatment approach for major depressive disorder and treatment-resistant depression. 

Released: November 12, 2024

Expiration: November 11, 2025

Share

Faculty

Lisa Harding

Lisa Harding, MD

Assistant Clinical Professor of Psychiatry
Yale School of Medicine
Medical Director, Mood Institute
Milford, Connecticut

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from AbbVie Inc. and Intra-Cellular Therapies, Inc.

AbbVie Inc.

Intra-Cellular Therapies, Inc.

Disclosure

Primary Author

Lisa Harding, MD

Assistant Clinical Professor of Psychiatry
Yale School of Medicine
Medical Director, Mood Institute
Milford, Connecticut

Lisa Harding, MD: consultant/advisor/speaker: Compass Pathways, Janssen Scientific Affairs, Otsuka.